Human Genome Epidemiology Literature Finder
|
Records 1 - 22 (of 22 Records) |
| Query Trace: Neoplasms and FAT3[original query] |
|---|
| A Population-Based Study of Four Genes Associated with Heroin Addiction in Han Chinese. PloS one 0 11 (9): e0163668. Li Yunxiao, Qiao Xiaomeng, Yin Fangyuan, Guo Hao, Huang Xin, Lai Jianghua, Wei Shugua |
| The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer. Journal of thoracic disease 2018 May 10 (5): 2948-2959. Lv Tangfeng, Zou Qian, Song Zhengbo, Liu Hongbing, Wang Qiming, Song Yo |
| Biological background of the genomic variations of cf-DNA in healthy individuals. Annals of oncology : official journal of the European Society for Medical Oncology 2018 11 30 (3): 464-470. Liu J, Chen X, Wang J, Zhou S, Wang C L, Ye M Z, Wang X Y, Song Y, Wang Y Q, Zhang L T, Wu R H, Yang H M, Zhu S D, Zhou M Z, Zhang X C, Zhu H M, Qian Z |
| Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11). Breast cancer research and treatment 2019 8 178 (2): 367-377. Kim Ji-Yeon, Lee Eunjin, Park Kyunghee, Im Seock-Ah, Sohn Joohyuk, Lee Keun Seok, Chae Yee Soo, Kim Jee Hyun, Kim Tae-Yong, Jung Kyung Hae, Park Yeon Hee, |
| Genetic landscape of external auditory canal squamous cell carcinoma. Cancer science 2020 6 111 (8): 3010-3019. Sato Kuniaki, Komune Noritaka, Hongo Takahiro, Koike Kensuke, Niida Atsushi, Uchi Ryutaro, Noda Teppei, Kogo Ryunosuke, Matsumoto Nozomu, Yamamoto Hidetaka, Masuda Muneyuki, Oda Yoshinao, Mimori Koshi, Nakagawa Takas |
| Association of clinico-genomic characteristics with tumor mutational burden in small cell lung cancer patients. Future oncology (London, England) 2020 11 17 (4): 423-433. Kachroo Sumesh, Shao Changxia, Desai Kaushal, He Jinghua, Jin Fan, Sen Shuva |
| FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer. Frontiers in oncology 2021 11 603660. Guo Zixin, Yan Xin, Song Congkuan, Wang Qingwen, Wang Yujin, Liu Xiao-Ping, Huang Jingyu, Li Sheng, Hu Weido |
| Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients. Aging 2021 Mar 13 (6): 9043-9055. Peng Linglong, Li Yang, Gu Haitao, Xiang Ling, Xiong Yongfu, Wang Rong, Zhou He, Wang Jiji |
| Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation. Oncoimmunology 2021 2 10 (1): 1865670. Nie Wei, Gan Lu, Wang Xin, Gu Kai, Qian Fang-Fei, Hu Min-Juan, Zhang Ding, Chen Shi-Qing, Lu Jun, Cao Shu-Hui, Li Jing-Wen, Wang Yue, Zhang Bo, Wang Shu-Yuan, Li Chang-Hui, Yang Ping, Xu Mi-Die, Zhang Xue-Yan, Zhong Hua, Han Bao-H |
| Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer. BioMed research international 2021 12 2021 8072796. Xu Zhiquan, Xiang Ling, Wang Rong, Xiong Yongfu, Zhou He, Gu Haitao, Wang Jijian, Peng Linglo |
| CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients. International journal of general medicine 2021 14 7647-7657. Lu Nan, Liu Jinhui, Xu Mengting, Liang Jianqiang, Wang Yichun, Wu Zhipeng, Xing Yan, Diao Feiya |
| Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients. International journal of clinical oncology 2021 Jan . Feng Feiling, Wu Xiaobing, Shi Xiaoliang, Gao Qingxiang, Wu Yue, Yu Yong, Cheng Qingbao, Li Bin, Yi Bin, Liu Chen, Hao Qing, Zhang Lin, Gao Chunfang, Jiang Xiaoqi |
| Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer. JCI insight 2022 Aug 7 (16): . Mai Zihang, Yuan Jianye, Yang Hong, Fang Shuogui, Xie Xiuying, Wang Xinye, Xie Jiaxin, Wen Jing, Fu Jianh |
| Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy. Frontiers in oncology 2022 12 844527. Du Juan, Qiu Xin, Lu Changchang, Zhu Yahui, Kong Weiwei, Xu Mian, Zhang Xin, Tang Min, Chen Jun, Li Qi, Li Aimei, He Jian, Gu Qing, Wang Lei, Qiu Yudong, Liu Baor |
| Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes. Frontiers in cell and developmental biology 2022 4 10 772701. Shen Xiaoyan, Gu Xiao, Ma Ruiqiong, Li Xiaoping, Wang Jianl |
| Somatic mutations in FAT cadherin family members constitute an underrecognized subtype of colorectal adenocarcinoma with unique clinicopathologic features. World journal of clinical oncology 2022 11 13 (10): 779-788. Wang Liang-Li, Zheng Wei, Liu Xiu-Li, Yin Fe |
| Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy. Frontiers in immunology 2021 12 800951. Zhu Mingyu, Zhang Lu, Cui Haiyan, Zhao Qiang, Wang Hao, Zhai Baochao, Jiang Richeng, Jiang Zhanshe |
| Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials. Annals of oncology : official journal of the European Society for Medical Oncology 2023 9 . F André, F Su, N Solovieff, G Hortobagyi, S Chia, P Neven, A Bardia, D Tripathy, Y-S Lu, A Lteif, T Taran, N Babbar, D Slamon, C L Artea |
| Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
| TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC. Frontiers in bioscience (Landmark edition) 2023 8 28 (7): 147. Huijing Feng, Huiru Xu, Xiuhuan Shi, Guobin Ding, Cihui Yan, Linhan Li, Zuoyi Jian, Xuejing Yang, Hongxia Guo, Feng Li, Junping Zhang, Xiubao R |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. Cancer medicine 2023 6 . Xiaoling Duan, Man Zhao, Xiaolei Yin, Lili Mi, Jianfei Shi, Ning Li, Xin Han, Guangjie Han, Jinfeng Wang, Jiaojiao Hou, Fei Y |
| Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients. Cancer genetics 2024 6 286-287 11-17. Caglar Berkel, Ercan Cac |
- Page last reviewed:Feb 1, 2024
- Content source: